肾动脉射频消融术治疗难治性高血压的研究及问题探讨
被引量：1
摘要
目前，高血压已成为严重影响我国人民健康的重大公共卫生课题。据卫生部统计资料，高血压及心脑血管疾病已占我国人口死因构成的40％。因此有效控制高血压，提高高血压的控制率是当前预防和控制心血管疾病的重要任务。
出处
《中国医药》
2013年第5期714-716,共3页
China Medicine
参考文献31
-
1中华人民共和国卫生部.2009年部分市县前t位疾病死亡专率及死亡原因构成(合计)//2011年中国卫生统计提要.2011-05-27[2012-03-25].http://www.mob,gov.cn/publicfites/busi.ness/htmlfiles/mohwsbwstjxxzx/s7967/201105/51862.htm.
-
2Hajjar I, Kotchen TA. Trends in prevalence, awareness, treat- ment, and control of hypertension in the United States, 1988-2000. .lAMA, 2003,290 ( 2 ) : 199-206.
-
3Smithwick RH, Thompson JE. Splanchnieectomy for essential hy- pertension; results in 1, 266 cases. J Am Med Assoc, 1953,152 (16) :1501-1504.
-
4Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet, 1953,1 (6757) :403-408.
-
5Schlaich MP, Socratous F, Hennebry S, et al. Sympathetic activa- tion in chronic renal failure. J Am Soc Nephrol, 2009,20(5) :933- 939.
-
6Esler M, Jemaings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens, 1989,2(3 Pt 2) :140-146S.
-
7Krum H, Sobotka P, Mahfoud F, et al. Device-based antihyperten- sire therapy: therapeutic modulation of the autonomic nervous sys- tem. Circulation, 2011,123(2) :209-215.
-
8Katholi RE. Renal nerves and hypertension: an update. Fed Proc, 1985,44(13) :2846-2850.
-
9Katholi RE, Winternitz SR, Oparil S. Decrease in peripheral sym- pathetic nervous system activity following renal denervation or un- clipping in the one-kidney one-clip Goldblatt hypertensive rat. J Clin Invest, 1982,69( 1 ) :55-62.
-
10O'Hagan KP, Thomas GD, Zambraski EJ. Renal denervation de- creases blood pressure in DOCA-treated miniature swine with estab- lished hypertension. Am J Hypertens, 1990,3 ( 1 ) :62-64.
同被引文献28
-
1World Health Organisation. The top 10 causes of death. 2011: Available at : http ://www.who.int/mediacentre/factsheets/fs310/ en/index.html (accessedl2/05,2014).
-
2Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension : analysis of worldwide data. Lancet,2005,365 : 217-223.
-
3Pouher N. Global risk of cardiovascular disease. Heart,2003,89: ii2-ii5.
-
4Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study : a cohort study. Lancet, 2001,358 : 1682-1686.
-
5Mancia G. Blood pressure reduction and cardiovascular outcomes: past, present, and future. Am J Cardiol, 2007,100 : 3J-9J.
-
6Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation, 2008,117 : e510-526.
-
7Sarafldis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coil Cardiol,2008,52: 1749- 1757.
-
8Sehlaich MP, Krum H, Sobotka PA, et al. Renal denervation and hypertension. Am J Hypertens, 2011,24: 635-642.
-
9DiBona GF. Neural control of the kidney: past, present, and future. Hypertension, 2003,41 : 621-624.
-
10Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension : review of 122 cases. Lancet, 1953,1 : 403 -408.
-
1霍勇,徐希平.加强H型高血压的防治[J].健康指南（中老年）,2012(10):8-9. 被引量：7
-
2程瑞迎.氨氯地平和坎地沙坦对2型糖尿病合并高血压患者血清炎症因子和颈动脉内中膜厚度的影响[J].中国药物与临床,2011,11(12):1439-1440. 被引量：2
-
3李莉,姜玉新,乌正赉,纪宝华.高血压及心脑血管疾病与颈动脉粥样硬化[J].中华心血管病杂志,1996,24(2):126-129. 被引量：115
-
4鞠晏钟,曹传洲,刘建珍.心脑血管疾病患者进行颈动脉超声检测的临床意义[J].山东医药,2001,41(10):44-44.
-
5王爱敏,张惠玲,袁书刚,郑焕成.胰岛素在高血压发病中的作用研究(附243例观察)[J].临床医学,2001,21(3):47-48.
-
6吴建贵.瘦素与高血压及心脑血管疾病[J].中外医疗,2009,28(22):185-185.
-
7刘淑华.非酒精脂肪性肝病的基础诊疗[J].中国医药指南,2013,11(9):68-69. 被引量：5
-
8罗晓勘,范戎.冠心病易患、预测因素研究进展[J].医学研究杂志,1997,31(8):23-25.
-
9李少玺,张丽,乔钦增,魏双平.河北省邢台地区成人高血压相关危险因素流行病学调查研究[J].中国药物与临床,2012,12(1):53-54.
-
10王常青,马骏华.静脉麻醉胃镜检查156例临床护理[J].齐鲁护理杂志,2008,14(12):114-115. 被引量：2
